Patient-guided dose reduction of tyrosine kinase inhibitors in chronic myeloid leukaemia (RODEO study): study protocol for a prospective, multicentre, single-arm trial

Autor: Melissa F Djodikromo, Rosella PMG Hermens, Bart JF van den Bemt, Yolba Smit, Tim M Govers, Charlotte L Bekker, Nicole MA Blijlevens

Publikováno v: BMC Cancer, Vol 23, Iss 1, Pp 1-9 (2023)

Abstract Background Dose reduction of tyrosine kinase inhibitors (TKI) in patients with chronic myeloid leukaemia (CML) with an optimal response to TKIs may support cost-effective medication use by maintaining therapeutic effectiveness while reducing

Externí odkaz: https://doaj.org/article/660c43c24cb144448a2c018c9ee34ecb

Cancer Survivorship Care: Person Centered Care in a Multidisciplinary Shared Care Model

Autor: Jacqueline Loonen, Nicole MA Blijlevens, Judith Prins, Desiree JS Dona, Jaap Den Hartogh, Theo Senden, Eline van Dulmen-Den Broeder, Koos van der Velden, Rosella PMG Hermens

Publikováno v: International Journal of Integrated Care, Vol 18, Iss 1 (2018)

Survivors of childhood and adult-onset cancer are at lifelong risk for the development of late effects of treatment that can lead to serious morbidity and premature mortality. Regular long-term follow-up aiming for prevention, early detection and int

Externí odkaz: https://doaj.org/article/1889365c003d469bbc4b4690405c5d9f

The Effectiveness of the Digital Care Platform CMyLife for Patients With Chronic Myeloid Leukemia: Patient-Preference Trial (Preprint)

Autor: Lynn Verweij, Geneviève ICG Ector, Yolba Smit, Bas van Vlijmen, Bert A van der Reijden, Rosella PMG Hermens, Nicole MA Blijlevens

BACKGROUND The two most important factors determining treatment success in chronic myeloid leukemia (CML) are adequate medication compliance and molecular monitoring, but both are still suboptimal. The CMyLife platform is an eHealth innovation, co-cr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5c36224d3111711a753948894477adbd
https://doi.org/10.2196/preprints.30844

The Development of a Web-Based, Patient-Centered Intervention for Patients With Chronic Myeloid Leukemia (CMyLife): Design Thinking Development Approach (Preprint)

Autor: Geneviève ICG Ector, Peter E Westerweel, Rosella PMG Hermens, Karin AE Braspenning, Barend CM Heeren, Oscar MF Vinck, Jan JM de Jong, Jeroen JWM Janssen, Nicole MA Blijlevens

BACKGROUND With the global rise in chronic health conditions, health care is transforming, and patient empowerment is being emphasized to improve treatment outcomes and reduce health care costs. Patient-centered innovations are needed. We focused on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::795ac21f98ebaddd10f07aaef964af17
https://doi.org/10.2196/preprints.15895

Overtreatment in couples with unexplained infertility

Autor: F. A. M. Kersten, Ben W.J. Mol, Mariëtte Goddijn, Rosella Pmg Hermens, Didi D.M. Braat, Willianne L.D.M. Nelen, Annemieke Hoek

Publikováno v: Human reproduction (Oxford, England), 30(1), 71-80. Oxford University Press
Human Reproduction, 30, 1, pp. 71-80
Human Reproduction, 30(1), 71-80. Oxford University Press
Human Reproduction, 30, 71-80

Item does not contain fulltext STUDY QUESTION: What is the percentage of overtreatment, i.e. fertility treatment started too early, in couples with unexplained infertility who were eligible for tailored expectant management? SUMMARY ANSWER: Overtreat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af71fdfe995741b4aff7ffd734ae71de
https://doi.org/10.1093/humrep/deu262